Skip to main content
. 2023 Jan 9;7(1):e22.00261. doi: 10.5435/JAAOSGlobal-D-22-00261

Table 1.

Patient Demographics

Demographic Total Aseptic Septic P value
n = 51 n = 27 (52.9%) n = 24 (47.1%)
Age, yearsa 61.4 ± 17.4 63.6 ± 19.6 58.9 ± 14.7 0.343
Male 35 (68.6%) 21 (77.8%) 14 (58.3%) 0.135
BMIa 30.8 ± 6.5 29.5 ± 6.0 32.2 ± 6.9 0.135
Comorbiditiesb 3.2 ± 2.0 2.8 ± 1.9 3.4 ± 2.1 0.333
Chronic obstructive pulmonary disease 2 (3.9%) 2 (7.4%) 0 (0.0%) 0.170
Hyperlipidemia 15 (29.4%) 10 (37.0%) 5 (20.8%) 0.205
Osteoarthritis 7 (13.7%) 5 (18.5%) 2 (8.3%) 0.255
Rheumatoid arthritis 1 (2.0%) 0 (0.0%) 1 (4.2%) 0.284
Hypothyroidism 8 (15.7%) 5 (18.5%) 3 (12.5%) 0.555
Cerebrovascular disease 3 (5.9%) 2 (7.4%) 1 (4.2%) 0.623
Peptic ulcer disease 3 (5.9%) 2 (7.4%) 1 (4.2%) 0.623
Hypertension 31 (60.8%) 17 (63.0%) 14 (58.3%) 0.735
Heart arrhythmia 5 (9.8%) 3 (11.1%) 2 (8.3%) 0.739
Coronary artery disease 8 (15.7%) 4 (14.8%) 4 (16.7%) 0.856
Chronic kidney disease 9 (17.7%) 5 (18.5%) 4 (16.7%) 0.863
Peripheral vascular disease 4 (7.8%) 2 (7.4%) 2 (8.3%) 0.902
Liver disease 4 (7.8%) 2 (7.4%) 2 (8.3%) 0.902
Dementia 2 (3.9%) 1 (3.7%) 1 (4.2%) 0.932
Cancer 2 (3.9%) 1 (3.7%) 1 (4.2%) 0.932
Diabetes 19 (37.3%) 10 (37.0%) 9 (37.5%) 0.973
a

Age, body mass index, and the number of comorbidities were normally distributed; therefore, they are reported as mean ± SD

b

Only comorbidities considered in the Charlson Comorbidity Index affecting at least one patient or those affecting five or more patients in the total cohort are reported here